Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.
about
Preclinical evidence of rapid-onset antidepressant-like effect in Radix Polygalae extractPiracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptorsProbing the Allosteric Modulator Binding Site of GluR2 with Thiazide DerivativesMolecular Mechanism of Flop Selectivity and Subsite Recognition for an AMPA Receptor Allosteric Modulator: Structures of GluA2 and GluA3 in Complexes with PEPAStructural and Functional Analysis of Two New Positive Allosteric Modulators of GluA2 Desensitization and DeactivationFunctional analysis of a novel positive allosteric modulator of AMPA receptors derived from a structure-based drug design strategyDual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugsCyclothiazide-induced persistent increase in respiratory-related activity in vitroNew therapeutic targets for mood disordersBipolar disorder: candidate drug targets.Molecular targets for treating cognitive dysfunction in schizophrenia.High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptors.Age-Dependent Modifications of AMPA Receptor Subunit Expression Levels and Related Cognitive Effects in 3xTg-AD Mice.Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder.AMPA receptor regulation at the mRNA and protein level in rat primary cortical culturesCharacterizing single-channel behavior of GluA3 receptorsGlutamatergic modulators: the future of treating mood disorders?A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.The effects of huperzine A and IDRA 21 on visual recognition memory in young macaquesIdentification of novel modulators for ionotropic glutamate receptor, iGluA2 by in-silico screeningAMPA receptor potentiators: from drug design to cognitive enhancementStructure of an agonist-bound ionotropic glutamate receptorNovel glutamatergic agents for major depressive disorder and bipolar disorder.Fetal alcohol spectrum disorders and abnormal neuronal plasticity.Glutamate receptor subunit expression in the rhesus macaque locus coeruleusNeural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targetsInvolvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test.The role of AMPA receptor modulation in the treatment of neuropsychiatric diseasesTargeting the glutamatergic system to develop novel, improved therapeutics for mood disordersIonotropic glutamate receptors & CNS disorders.Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networksThe role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.Are AMPA receptor positive allosteric modulators potential pharmacotherapeutics for addiction?Glutamate receptors as therapeutic targets for Parkinson's disease.Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update.The treatment of cognitive impairment in schizophrenia.Emerging drugs for schizophrenia.Glutamate system as target for development of novel antidepressants.
P2860
Q21132322-ED89A661-DFF1-4C36-A41A-DC71EBF2374FQ24611731-B6A31018-7F2B-4B91-A42B-E0AD7DD10864Q27656975-FBC7B57A-EC64-4CDF-AD65-63ACC74AD517Q27660095-E172E251-4E10-478F-8B09-6AEADFF6A5B9Q27667701-CD9D158A-7A9D-4346-ADE6-1DD72517DC44Q27681406-FF3D390E-E860-40AF-8DC4-43E0369D7EFEQ28305100-0BFF356C-4A7D-426C-BD4F-1BDD8772BA1EQ28714282-B04BD2EE-F6CB-4977-B1EE-EB56EF834A5FQ28743068-4D1B504B-D668-45E2-93EF-CA741C6C14F7Q28751133-0D202301-3C67-4EF1-AA08-AA481609399BQ30491310-92B7F61A-8524-4119-84E1-2207535048E8Q33538463-A4904DE0-35AB-4718-AC3D-31FE80931B51Q34003920-D0C5857F-6ED2-45BC-9D6B-286A9597954BQ34033559-982CFC91-274D-461D-BADA-D48A7746B2A4Q34038248-69671044-E228-480D-BFD0-834011E0B330Q34099097-ECB6F835-BC62-46E1-96BB-0146EC2E8683Q34398007-3EA5F81E-5D09-4BC8-8134-8E663EBAD1C0Q34579324-31BBCBB1-AC01-4A4C-843F-2EDA09CE339AQ34766451-3B5B73A6-5B59-4F66-9EA8-F3A98E88B926Q34775101-AABE9F19-38DA-483D-94D7-6EF0101B43C5Q34820857-33FC277E-2D93-43E5-826F-3A1233018A78Q35054673-496836BE-5D6A-4F89-BC54-52806728015FQ35247269-33449A17-EEA9-4737-BBCF-F99DD09A4696Q35661119-5518EDD6-AF37-4F32-94D7-3EAE98699515Q35915502-1E7530B5-FA32-46E8-B007-F516B1619298Q36122888-02E2017A-26F3-4051-9829-8D86B07F45EEQ36401907-F6CFD5A9-375B-4A18-A593-ABA6A63BB3D1Q36509014-42356946-AB98-46A6-857A-C8964B4C2E0FQ36740187-777D5D56-0A99-4CDD-BAAA-6D15D8076CBDQ37143117-B18DCDA8-11C8-4172-912D-A798E0BC8353Q37143580-0AA90EC7-7F0C-434C-BE07-5086BB63ED07Q37220392-734889D7-9162-4221-9416-0020A42A16CBQ37387700-BDF500E9-58AB-4943-BCA2-FD77B559DB15Q37442874-A26CC908-C1E1-44CB-987C-7613A1841432Q37559271-B38D77CA-B58D-4A19-9D0F-7B9AFFD97524Q37585401-350A9432-854A-48F3-A06B-1CB6F8C23B3BQ37621271-3E35CAC9-F411-46A2-9D6A-8DD4B92CEAE4Q37813206-8B024777-2E3C-4637-8207-E17079AD5FCAQ37874626-B335DA29-E7DC-47B7-BB95-7D4B0FCDF855Q38078152-BDB5C841-C1F0-405C-8C86-8D40DF09618A
P2860
Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Therapeutic potential of posit ...... A review of preclinical data.
@ast
Therapeutic potential of posit ...... A review of preclinical data.
@en
type
label
Therapeutic potential of posit ...... A review of preclinical data.
@ast
Therapeutic potential of posit ...... A review of preclinical data.
@en
prefLabel
Therapeutic potential of posit ...... A review of preclinical data.
@ast
Therapeutic potential of posit ...... A review of preclinical data.
@en
P1433
P1476
Therapeutic potential of posit ...... A review of preclinical data.
@en
P2093
Mark D Black
P2888
P304
P356
10.1007/S00213-004-2065-6
P577
2005-01-26T00:00:00Z
P6179
1030738633